1. The serum bile acid disappearances of tracer doses of [24-"ClchoIic acid and [ l-"Clglycocholic acid were studied in eight normal subjects and 11 patients with chronic liver disease (with or without cholestasis) in order to determine the effect of liver disease on hepatic clearances, reflux of conjugated cholic acid and initial distribution volume of each tracer.
1. The serum bile acid disappearances of tracer doses of [24-"ClchoIic acid and [ l-"Clglycocholic acid were studied in eight normal subjects and 11 patients with chronic liver disease (with or without cholestasis) in order to determine the effect of liver disease on hepatic clearances, reflux of conjugated cholic acid and initial distribution volume of each tracer.
2. Total cholic acid clearance was significantly reduced from normal (7.2 & 0.7 ml min-l kg-l, mean & SE) in patients with liver disease (69-88%, group means) as were unconjugated cholic acid (5 1-68%) and glycocholic acid (66-83%) clearance.
3. Extensive regurgitation of labelled conjugated cholic acid (after unconjugated cholic acid tracer injection) among cholestatic patients accounted for 69 f 5% of total 14C remaining in serum at 70 min, thus masking a less-impaired uptake process.
4. The hepatic extraction efficiency for conjugated cholic acid among controls (86 & 8%) was greater than that for unconjugated cholic acid (60 4%), and was greatly reduced among patients (7-27%, group means). 5. Normal subjects and patients with cirrhosis without cholestasis did not distribute the isotope to extravascular, extrahepatic spaces, in contrast to cholestatic patients with serum bile acid concentra-
Introduction
Mechanisms involved in the hepatic metabolism and transport of bile acids and other organic anions have been investigated in several animal species (O'Maille, Richards & Short, 1965; Gronwall, Engelking, Anwer. Erichsen & Klentz, 1975; Anwer, Engelking, Gronwall & Klentz, 1976a; Anwer, Gronwall, Engelking & Klentz, 1976b; Engelking, Gronwall & Anwer, 1976 : Paumgartner & Reichen. 1976 . Investigators have attempted to characterize the serum disappearance of injected l4C-labeIled bile acid in normal man and in patients with liver disease (Blum & Spritz, 1966; Theodor, Spritz & Sleisenger, 1968; Cowen, Korman, Hofmann & Thomas, 1975; Horak, Waldram, Murray-Lyon, Schuster & Williams, 1976) in whom the serum bile acid concentrations are usually elevated (Rudman & Kendall, 1957; Osborn, Wootton, DaSilva & Sherlock, 1959; Barnes, Gallo, Trash & Morris, 1975; Schwarz, Paumgartner & Preisig, 1975; Demers & Hepner, 1976) in order to gain an understanding of the nature of the hepatic dysfunction. They have either determined the half-life of various components of the blood disappearance curves in order to describe 'hepatic elimination', or the percentage of labelled conjugated cholic acid at specified intervals after injection of an unconjugated bile acid tracer as a measure of hepatic metabolic function. Compartmental analysis using the parameters of the serum disappearance curves has been carried out for many drugs with the open two-compartment model described by Richards, Tindall & Young (1959) . However, this approach may be inappropriate. Forker & Luxon (1978) examined the errors created by the 'lumped' model, which has a single well-mixed blood compartment compared with one which separates the splanchnic and peripheral circulations, and have shown that only three parameters can be reliably estimated: the serum clearance, the biliary output rate constant and the initial volume of distribution.
The objectives of this study were to evaluate serum, i.e. hepatic, clearance of both unconjugated and conjugated [14Clcholic acid in normal subjects and in patients with liver disease. Since cholestasis was presumed to cause reflux into blood of [14C]-cholic acid conjugated in the liver, comparison was made between the different groups of patients with liver disease to delineate the effects of conjugation on serum clearance.
Methods

Clinical studies
Experiments were performed in 19 fasting subjects: eight normal volunteers without evidence of hepatobiliary or gastrointestinal disease, and 11 patients with liver disease, six with well-established yet compensated cirrhosis of various aetiologies, and five with advanced cholestasis (three with primary biliary cirrhosis, two with sclerosing cholangitis). The experimental protocol was approved by the University Human Use Committee with informed written consent from each patient. The clinical data for each subject studied are provided in Table 1 . and [ l-14C1glycocholic acid (specific radioactivity 30.7 pCi/pmol) (New England Nuclear, Boston, Mass., U.S.A) were found to be greater than 97% pure by thin-layer chromatography. Normal subjects received 50 pCi, and patients with hepatobiliary disease 12-36 pCi, of [24-14C1cholic acid. The elevated concentrations of labelled compounds were required for additonal long-term serum specific radioactivity-turnover studies. After those studies, subjects were given 10 pCi of [l-14C1-glycocholic acid. The labelled compounds were dissolved in 8 mi of sterile sodium chloride solution (1 54 mmol/l) and injected intravenously over a 5-10 s period. Blood samples (5 ml) were removed from an opposite antecubital vein at 2, 4, 6, 8, 10, 12, 15, 20, 25, 30, 40 , 50, 60 and 70 min after injection. Urine was obtained at the end of each study. After clotting, the blood was centrifuged and the radioactivity in serum (0.5 ml) was determined with a Packard Tri-Carb liquid scintillation spectrometer after additon of 10 ml of Beckman Ready-Soh H.P. scintillation cocktail. Corrections for quenching were made with automatic external standardization.
Separation and measurement of bile acids
To determine the extent of conjugated cholic acid reflux after [24-14Clcholic acid injection, bile acids in serum (1 ml diluted with 9 ml of NaOH (0. I mol/l)] were extracted by adsorption on to columns of Amberlite XAD-2 (Schwarz, Bergmann & Paumgartner, 1974) , followed by elution with methanol. The eluate was evaporated to dryness and the bile acids were resuspended in 100 pI of ethanol. Each sample (60 pl) was spotted on silica gel (Polygram sil G; Brinkmann Instruments Inc.) in 20 cm x 20 cm thin-layer plates and developed in dichloroethane/acetic acid/water (10: 10 : 1.5, by vol.). The bile acids were visualized by spraying with ethanolic 15% phosphomolybdic acid and heating. The cholic acid, taurocholic acid and glycocholic acid areas were cut from the thinlayer plates and dissolved in 14 ml of Beckman Ready-Soh H.P. for liquid-scintillation counting. The glycocholic acid/taurocholic acid (GC/TC) ratios were determined for each sample, as were the conjugated (GC + TC) and unconjugated 
where total [24-14Clcholic acid = % of injected dosen of serum (determined from total radioactivity counts in 0.5 ml of serum), CCA is conjugated cholic acid (d.p.m. from thin-layer chromatography) and UCA is unconjugated cholic acid (d.p.m. from thin-layer chromatography). The conjugated fraction was expressed as a percentage of total 14C radioactivity.
Conjugated fraction (%)
Serum bile acid concentrations were determined by a 12sI radioimmunoassay method with a taurocholic acid standard (Spenney, Johnson, Hirschowitz, Mihas & Gibson, 1977) . This method detects the primary conjugated bile acids and shows good correlation ( r = 0.84. n = 149, regression line radioimmunoassay = 1.15 x enzyme value + 3.7) with 'total' serum bile acids measured by the 3cehydroxysteroid dehydrogenase procedure (Barnes & Chitranukroh, 1977) .
Data analysis
The non-linear serum disappearance curves (expressed as % of injected dose/l of serum) were fitted to the sums of three exponential functions with an IBM digital computer programme after estimates and limits of the intercepts and slopes of the exponential functions were determined by integration peeling (Metzler, 1970; Engelking et al., 1976) . The non-linear fit to each observed curve was calculated according to the method of Metzler (1970) . which minimized the fractional sums of squared deviations.
Three exponential functions were both adequate and necessary to fit the data over 70 min periods. The equations took the form:
(2) Initial volume of distribution (litres)
Hepatic extraction efficiency (Oh) = (k,/0.28)100 (7) Assuming the proportion of cardiac output passing through the liver each minute is 0.28 (Barrett et al., 1968) . hepatic extraction efficiency can be determined from the serum disappearance curves.
Under steady-state conditions and a constant serum bile acid concentration during each clearance study (as was observed) the mass of bile acid moving out of and hence into the peripheral compartment was defined as the peripheral compartment flux.
Peripheral compartment flux (nmol/min) = clearance (ml/min). [bile acid] (nmol/ml)
where [bile acidl denotes the steady-state fasting clearance bile acid concentration. The plasma volumes (not significantly different from the 12'I-labelled serum albumin space of selected subjects, paired f-test, P > 0.5) were determined from estimates of body surface area (Diem & Lentner, 1970) .
Data presentation
In order to decrease the variance between patients due to body size, the data were normalized for both figurative and statistical comparison. Clearance and peripheral compartment flux were expressed per kg body weight. Since the initial volume of distribution approximated to the plasma volume (Table 3) , each non-linear intercept parameter (A, B and 0 was divided by the sum of A , B and C to allow figurative comparison of patient groups (Fig. I) . Individual statistical comparisons were preceded by adjusting each intercept to 70 kg body weight.
Analysis of variance, paired t-test and Duncan's multiple range test (Snedecor & Cochran, 1967) were used to detect differences between calculated parameters.
Results
The deviation between observed and fitted values of each serum disappearance curve was small ( R 2 > 0.99), as were the asymptotic SE values for each calculated parameter. The parameters of the third exponential component (Cwlk,) were significantly greater than zero. No evidence for enterohepatic cycling (0-70 min) was found. The third exponential component (Cwlk,) was increased in both patient groups with each isotope (Table 2) . Although the first component (Awlk,) was reduced in both patient groups, the second component (Bw/k,) was variably changed.
Total cholic acid clearance (eqn. 5 ) was significantly reduced (P < 0.05) from normal in patients with cirrhosis (by 69%) and in those with majority of [14Clcholic acid at 70 min in the perk cholestasis (by 88%) (Table 3) . Although there was pheral blood of patients with cholestasis was conjunot a significant reflux of conjugated cholic acid gated (69 f 5.4%) after unconjugated cholic acid above normal in patients with cirrhosis, the injection (Table 3) . When the conjugated compo- nent was subtracted from the total cholic acid activity (eqn. l), the resulting unconjugated cholic cant group or individual differences (analysis of variance, P > O-S), nor were they significantly acid clearance reflected an uptake 56% greater in the cholestatic (3.9 f 0.5 ml min-I kg-I) than in the cirrhotic group (2.5 f 0.5 ml min-I kg-I). Both were significantly reduced (51 and 68% respectively) from normal ( Fig. 1 and Table 3 ).
[ l-14C1Glycocholic acid clearance resulted in group reductions from control (66% cirrhosis, 83% cholestasis) similar to those for total cholic acid clearance (69% cirrhosis, 88% cholestasis). The hepatic extraction efficiencies (eqn. 7) for glycocholic acid (1 1-86%) were greater than those for total cholic acid (7-60%) in each group studied (Table 3) .
Patients exhibiting cirrhosis without cholestasis (cirrhotic group) showed a differential pattern of glycocholic acid relative to unconjugated cholic acid clearance (Fig. 2) . Three of six patients (E.S., L.O. and E.V.) cleared glycocholic acid 37-1 17% faster than unconjugated cholic acid (Table 3 and Fig. 2) . The remaining three patients represented 4-11% elevations similar to those in controls (14 f 3%, mean f SE). Those differences in glycocholic acid transport relative to the unconjugated form were taken to represent possible bile acidconjugating defects. different from a theoretical value of 3 (Duncan's multiple range test, P > 0.05).
Serum bile acid concentration was 37 times normal (0.5 f 0.1 pmol/l) in cirrhotic patients (19 f 6 pmol/l) and 217 times normal (109 k 32 pmol/l) in cholestatic patients. Subsequent determination of peripheral compartment flux (eqn. 8) indicated that patients with cirrhosis were transporting bile acid in and out of their peripheral circulation at a rate eight times faster than normal, and cholestatic patients at a rate 20 times above control (Table 3) .
The multiple range test of the initial volume of distribution (eqn. 4) and plasma volume (determinations reflected no significant differences between groups, yet there was a significant difference among cholestatic patients). Three patients, M.W., F.F. and R.T., showing the most marked cholestasis, with jaundice (total bilirubin 265-274 pmol/l), had initial volume of distribution/plasma volume ratios above normal. Similar distribution volumes were observed for studies with glycocholic acid.
Renal loss of injected I4C did not significantly contribute to the overall clearance since no subject excreted more than 1% of the injected dose during
The glycine/taurine ratios did not show signifi-the first 2 h after injection. Discussion Analysis of both conjugated and unconjugated [ 14C]cholic acid serum disappearance curves, combined with chromatographic separation of the labelled metabolites, provides valuable information for detecting and evaluating hepatic bile acidtransport defects among patients with liver disease.
A triple exponential function was required to describe the serum disappearance curves, as has been noted in similar studies (Klapdor, Bolte & Schlosser, 1975; Engelking & Gronwall, 1979) . The use of a double exponential function on a three-exponential curve can lead to an overestimation of the distribution volume (Thjodelifsson, Barnes, Chitranukroh, Billing & Sherlock, 1977) . Although normal subjects and cirrhotic patients without cholestasis exhibited identical initial volumes of distribution and plasma volumes, cholestatic patients with serum bile acid concentrations greater than 149 ,umol/l were apparently distributing the tracer to extrahepatic, extravascular spaces.
The terminal component (Cwlk,) for our clearance curves reflected the greatest contribution to the area and hence influenced the clearance process (as much as 80%). It should be noted that a true evaluation of serum clearance necessitates complete resolution of the serum disappearance curve, i.e., since the terminal component had a halflife of 20-60 min studies should be extended for at least 60 min and should have at least 12-15 data points.
In contrast to recent studies of glycocholic acid clearance among anicteric (serum bilirubin < 20 pmol/l) patients with chronic liver disease (Gilmore & Thompson, 1978) , our studies revealed a significant 62% reduction compared with the reported insignificant 7 -5% reduction. This may be explained by our patients being in a more advanced state of disease, although it is possible that these differences also relate to the non-linear analysis. Although our cholestatic patient group represented patients with either primary biliary cirrhosis (60%) or sclerosing cholangitis (4096), the reflux of conjugated cholic acid after injection of unconjugated cholic acid was nonetheless representative of their cholestatic condition. Reflux of conjugated cholic acid accounted for 69 f 18% of the [14C1cholic acid present in the peripheral circulation at 70 min after injection of the unconjugated acid. That resulted in a net 333% difference between hepatic clearances of unconjugated cholic acid and total cholic acid. Neither of these clearances alone could adequately evaluate the uptake process (unconjugated cholic acid clearance) in the presence of greatly enhanced isotopic reflux due to the predominating excretory impairments in these patients. The reduced unconjugated cholic acid clearance compared with that of controls did suggest, however, intra-as well as extra-hepatic involvement among those with primary biliary cirrhosis.
In three of six patients exhibiting cirrhosis without cholestasis, the reduced clearance of unconjugated cholic acid compared with glycocholic acid suggested a probable conjugation impairment. This was not observed among controls, nor in other patients studied. A reduced ability to conjugate cholic acid has been observed in patients with fulminant hepatic failure (Horak et al., 1976) .
Assuming that hepatic blood flow was similar among our normal and diseased patients (28% of cardiac output), the mean hepatic extraction efficiencies among controls (60-86%) were comparable with values determined in monkeys (44-99%) (Portman & Shah, 1962) , rats (95%) (Olivecrona & Sjovall, 1959) , dogs (79-92%) (O'Mallie, Richards & Short, 1967) and man (85%) (Gilmore & Thompson, 1978) . In contrast, patients with liver disease had greatly reduced extraction efficiency (7-27%), there being no significant difference between those with surgical shunts or varices to those without.
It would be unlikely that the 6 6 4 8 % mean reductions in hepatic clearance among the two patient groups reflected reductions in blood flow alone. Although one might expect that cirrhosis is associated with a decrease in portal blood flow, previous studies have suggested that many patients with cirrhosis, portal hypertension and oesophageal varices have normal or only slightly diminished blood flow where portal pressure was not reduced by medical therapy (Leevy, Colakoglu, TenHove & Stone, 1973) .
Although reduction in bile acid serum clearance was observed in both groups, the considerable increases in the serum bile acid conceitration (37-fold in cirrhotic patients, 2 17-fold in cholestatic patients) meant that the bile acid clearance from serum at the time of study (the fasting state) was markedly increased. It was not possible to assess whether serum bile acid clearance was dependent on the serum bile acid concentration with each patient. Previous studies (Korman, LaRusso, Hoffman & Hofmann, 1975) have shown that the normal liver has a large reserve capacity for uptake of glycocholic acid.
Although our patient groups were small, and the cholestatic group represented patients with intra-as well as extra-hepatic involvement, our results clearly indicate that careful analysis of serum '*C-labelled bile acid clearance curves, in combination with separate analysis of metabolites refluxing from the liver, can provide valuable information concerning the nature of the bile acid-transport process. Since many factors other than hepatocellular function contribute to serum bile acid concentration, intravenous 14C-labelled bile acid clearance and 14C-labelled metabolite analysis should continue to be evaluated clinically as a viable diagnostic resource.
